Free tool
Oncology stocks
We cover 3 companies grouped under the Oncology theme. The median market value in the group is $20.65B. Across the group, the median move over the past trading day is +1.16%. Price change over the past year runs from +1.2% to +52.9% across the middle 80 percent of the group, with a median of +50.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.49% | Oct 27, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +50.53% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.